![Senseonics, TypeZero and Roche Diabetes Care team-up to trial a long-term artificial pancreas system Senseonics, TypeZero and Roche Diabetes Care team-up to trial a long-term artificial pancreas system](https://mhealthspot.com/wp-content/uploads/eversense.jpg)
Senseonics, TypeZero and Roche Diabetes Care team-up to trial a long-term artificial pancreas system
![Chemosensors | Free Full-Text | Continuous Glucose Monitoring in Hypoxic Environments Based on Water Splitting-Assisted Electrocatalysis Chemosensors | Free Full-Text | Continuous Glucose Monitoring in Hypoxic Environments Based on Water Splitting-Assisted Electrocatalysis](https://www.mdpi.com/chemosensors/chemosensors-11-00149/article_deploy/html/images/chemosensors-11-00149-g001.png)
Chemosensors | Free Full-Text | Continuous Glucose Monitoring in Hypoxic Environments Based on Water Splitting-Assisted Electrocatalysis
![Implantable glucose sensor featuring IDT sensing technology awarded CE Mark - Medical Design and Outsourcing Implantable glucose sensor featuring IDT sensing technology awarded CE Mark - Medical Design and Outsourcing](https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2016/06/eversense-cgm-medical-technology.jpg)
Implantable glucose sensor featuring IDT sensing technology awarded CE Mark - Medical Design and Outsourcing
Roche Diabetes Care and Senseonics Announce Distribution Agreement for the Eversense® CGM System Introducing the First Implantable Long-term Glucose Sensor
![Biosensors | Free Full-Text | Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study Biosensors | Free Full-Text | Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study](https://www.mdpi.com/biosensors/biosensors-12-00106/article_deploy/html/images/biosensors-12-00106-g001-550.jpg)